Cargando…
Folate Augmentation of Treatment – Evaluation for Depression (FolATED): protocol of a randomised controlled trial
BACKGROUND: Clinical depression is common, debilitating and treatable; one in four people experience it during their lives. The majority of sufferers are treated in primary care and only half respond well to active treatment. Evidence suggests that folate may be a useful adjunct to antidepressant tr...
Autores principales: | Roberts, Seren Haf, Bedson, Emma, Hughes, Dyfrig, Lloyd, Keith, Moat, Stuart, Pirmohamed, Munir, Slegg, Gary, Tranter, Richard, Whitaker, Rhiannon, Wilkinson, Clare, Russell, Ian |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2238748/ https://www.ncbi.nlm.nih.gov/pubmed/18005429 http://dx.doi.org/10.1186/1471-244X-7-65 |
Ejemplares similares
-
Correction: Folate Augmentation of Treatment – Evaluation for Depression (FolATED): protocol of a randomised controlled trial
por: Roberts, Seren Haf, et al.
Publicado: (2009) -
FolC2‐mediated folate metabolism contributes to suppression of inflammation by probiotic Lactobacillus reuteri
por: Thomas, Carissa M., et al.
Publicado: (2016) -
The natural product carolacton inhibits folate-dependent C1 metabolism by targeting FolD/MTHFD
por: Fu, Chengzhang, et al.
Publicado: (2017) -
Enhancing rigour in the validation of patient reported outcome measures (PROMs): bridging linguistic and psychometric testing
por: Roberts, Gwerfyl, et al.
Publicado: (2012) -
Radiation dosimetry of (18)F-AzaFol: A first in-human use of a folate receptor PET tracer
por: Gnesin, Silvano, et al.
Publicado: (2020)